Business context and reporting period
Registrant: Allied Motion Technologies Inc. (NASDAQ: AMOT), a designer and manufacturer of controlled-motion products and systems serving vehicle, industrial, medical, and aerospace and defense markets. This is its unaudited Form 10-Q for the quarter ended March 31, 2020. The request metadata names “ALLIENT INC,” but the filing identifies the registrant as Allied Motion Technologies Inc.
All amounts below are in U.S. dollars; financial statement amounts are in thousands except per-share data. The company reports one operating segment.
Financial performance and liquidity
| Metric | Q1 2020 | Q1 2019 / comparison |
|---|---|---|
| Revenue | $92.382 million | $93.896 million; down 1.6% |
| Gross profit and margin | $28.042 million; 30.4% | $27.662 million; 29.5% |
| Operating income | $6.715 million; 7.3% margin | $7.327 million; 7.8% margin |
| Net income | $4.035 million | $4.470 million; down 9.7% |
| Diluted EPS | $0.42 | $0.48 |
| Operating cash flow | $(2.966) million | $(2.439) million |
| Capital expenditures | $1.696 million | $2.505 million |
Gross margin improved despite lower revenue, which management attributed to product mix and lower sales in the lower-margin vehicle market. Reported revenue excluding foreign-exchange effects was $93.805 million, roughly comparable with 2019; currency reduced reported revenue by about $1.423 million. EBITDA was $10.406 million versus $11.004 million; adjusted EBITDA was $11.442 million versus $11.731 million. Both are non-GAAP measures.
At March 31, cash was $20.383 million, current assets were $140.751 million, and current liabilities were $53.323 million (current ratio about 2.6). Long-term debt, net of issuance costs, was $136.244 million; cash less that debt was approximately negative $115.9 million. The revolving facility had approximately $88.073 million unused, subject to borrowing-base/covenant limitations. The company reported compliance with its financial covenants.
Cash increased $6.967 million during the quarter, primarily reflecting $26.979 million of debt borrowings. Investing cash use was $16.237 million, including $14.541 million paid for the Dynamic Controls acquisition, net of cash acquired. Working-capital needs contributed to negative operating cash flow.
Material changes versus the prior comparable period
- Revenue declined, with the largest market pressure in Vehicle; market revenue was $28.055 million versus $33.596 million. Industrial and Medical revenue increased to $33.351 million and $14.551 million, respectively, from $31.311 million and $12.410 million.
- Bookings were $92.923 million, down about 1%; backlog was $133.187 million, up about 2%, with the increase attributed to the Dynamic Controls acquisition.
- Operating expenses rose 5% to $21.327 million, including higher engineering, selling, and acquisition-related business development costs. Net income fell despite improved gross margin.
- On March 7, the company acquired Dynamic Controls for preliminary purchase consideration of $25.978 million. The business contributed $2.5 million in revenue and $125,000 in earnings after acquisition. Purchase-price allocation remained preliminary.
- The company amended and extended its revolving facility in February: capacity increased from $175 million to $225 million, with a $75 million accordion feature, improved pricing and covenants, and maturity extended to February 2025.
Outlook, commentary, and risks
Management said COVID-19 had disrupted North American operations and weakened demand, particularly in Vehicle. It expected social-distancing measures, supplier constraints, reduced production, and uncertainty to affect operations and demand more significantly in Q2 and possibly beyond. Most sites remained substantially operational as essential suppliers; the China facility had resumed full operation. Medical demand for components used in ventilators and other equipment increased, and the company expanded capacity for certain products.
No quantified revenue or earnings guidance was provided. Management expected 2020 remaining-period capital expenditures of $10–$12 million and stated that cash, anticipated operating cash flows, and borrowing flexibility were expected to meet ordinary-course needs for the next twelve months. It was conserving cash through cost alignment, hiring and wage freezes, and control of discretionary spending.
Key risks include the uncertain duration and severity of COVID-19 and its effects on customer demand, suppliers, workforce, operations, and cash flows; foreign-exchange exposure; customer concentration (one customer represented 13% of Q1 revenue and 13% of receivables at quarter-end); and debt covenant and borrowing availability. Foreign-currency translation reduced comprehensive income, with a $2.428 million translation loss in Q1. Management reported disclosure controls were effective and no material change in internal control over financial reporting.
Important facts for investors to verify
- Confirm the issuer identity: the filing is for Allied Motion Technologies Inc. (AMOT), not “Allient Inc.”
- Track subsequent COVID-19 effects on orders, backlog conversion, vehicle-market demand, supply continuity, and Q2 operations.
- Monitor acquisition integration, final purchase-price allocation, and whether expected synergies materialize.
- Assess cash conversion and working-capital trends alongside debt, covenant headroom, and actual revolver availability.
- Review foreign-exchange effects and the sensitivity of earnings and cash interest to currency and interest-rate movements.